Full service CRO in Europe for sale

Company for sale

• Sales: < 10 million EUR
• Location: Europe, exact location will be disclosed to seriously interested parties
• Reason for sale: The owners have decided to step out of the business they built, therefore they are ready to talk with strong players in the industry
• #CFIE PHS082

Overview of full-service CRO in Europe for sale

This is a best-in-class European CRO with a strong focus on small and mid-sized biopharma companies. It has strong expertise in key therapeutic areas, such as cardiovascular, infectious diseases, oncology, rare diseases, endocrinology, and CNS.

Profile (strategy) of full-service CRO in Europe for sale

The company provides a wide range of Phase I-IV clinical trial services, including pharmacovigilance and legal representation. Further, it has strong expertise in key therapeutic areas, such as cardiovascular, infectious diseases, oncology, rare diseases, endocrinology, and CNS. Above all, this expertise has allowed it to build strong relationships with key research sites and achieve low staff turnover, which ensures unparalleled knowledge retention.

Worldwide, the company has a global platform with over 75 experienced staff members and infrastructure across more than 15 countries in Europe and North America. It has already proven its ability to manage large-scale studies. In addition, it plans to add additional business development staff and services, such as data management and biostatistics. Consequently, the aim is to quickly grow the business into a truly full-service, global partner for larger trials.

Currently, the company is experiencing exceptional growth and profitability, with a revenue CAGR of 32% between 2020 and 2024 (projected) and adjusted EBITDA margins at 30%+ between 2022 and 2024 (projected). Furthermore, it is projecting an 81% adjusted EBITDA CAGR from 2020 to 2024. Most importantly, the management is confident in its ability to meet the 2023 projection fed by a strong backlog and pipeline. Additional business development staff added services and increased traction with recently launched pharmacovigilance services that will fuel future growth.

Strategically, the company is led by an experienced management team with significant regional expertise. The team has built its reputation and critical relationships over more than 25 years in the industry.

Activities and products of this full-service CRO in Europe for sale

Overall, the company provides a wide range of clinical trial services to pharmaceutical and biotechnology companies. Moreover, their services include clinical trial management, regulatory affairs, pharmacovigilance, data management, and biostatistics, among others. They also offer a number of specialized services, such as central laboratory services, clinical trial monitoring, and clinical research associate (CRA) services. Additionally, the company has a strong track record of success in CEE and has a deep understanding of the local regulatory environment.

Highlights of this full-service CRO in Europe for sale

• Strong track record of success in the CRO industry
• Global platform with over 75 experienced staff members
• Strong expertise in key therapeutic areas
• Exceptional growth and profitability

More information on this full service CRO in Europe for sale

Please get in touch if you are interested in learning more about this full service CRO in Europe for sale. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.